Effects of N-acetylcysteine on the quality of life, anxiety and antioxidant indexes of patients with cardiovascular disease.

Not Applicable

• Conditions: Condition 1: cardiovascular disease. Condition 2: cardiovascular disease.; Ischaemic heart diseases; 120-125

• Registration Number: IRCT2015121425526N1
• Lead Sponsor: orestan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Criteria
1. patients with acute coronary syndrome, coronary artery disease, the treating physician to confirm the diagnosis reached.
2 people (women and men) aged 65-18 years able to read and write their own.
3. People who have the full consent to participate in research.
4. People who have a history of these-acetylcysteine ??orally, by injection or inhalation during the first months of treatment have not.
5 people without a history of hypersensitivity reactions after taking it approved acetylcysteine
6. The people who received both medications or substances with antioxidant effects as vitamin E, A or vitamin A, E, vitamin C, at least one month before the quake
7. People with a history of anti-anxiety drugs, have.
8 people aged 65-18 years.
9. The lack of disease HCV +, HBSAg +, HIV +, diabetes, kidney disease,
10 of pregnancy
Exclusion criteria
(1) patients who can not understand the questions or did not have the time and location aware.
2. Patients in the study were dissatisfied.
3. Patients who withdrew during the study.
4. People who do not consume drugs.
5 people who died during the study.
6. Individuals involved in the research program to improve the quality of life or reduce anxiety, such as health promotion, and rehabilitation and so on are.
7 people in the business week by experts and researchers to track the phone call not to participate or not.
8. ejection fraction less than 40% for the echocardiogram

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life. Timepoint: After and before of the intervention. Method of measurement: MacNew Questionnaire.;Anxiety level. Timepoint: After and before of the intervention. Method of measurement: Spielberger Questionnaire.;Blood antioxidant biomarker indexes. Timepoint: After and before of the intervention. Method of measurement: biochemical assesing.

Secondary Outcome Measures

Name	Time	Method
-. Timepoint: -. Method of measurement: -.